Cambridge Epigenetix has used research into the role of the epigenome in disease to develop a non-invasive diagnostic kit for widespread cancer screening.
University programmes like Cambridge Enterprise and Accelerate are helping us to spin-out and nurture the ideas of our researchers and students into beneficial and practicable applications.